Article of interest: The C-reactive protein-to-prealbumin ratio predicts fistula closure

Posted on by
Reply

Harriman S, Rodych N, Hayes P, Moser MA. The C-reactive protein-to-prealbumin ratio predicts fistula closure. Am J Surg. 2011 Aug;202(2):175-8.

Full-text for Emory users.

Background: The purpose of this study was to evaluate the predictability of fistula closure using the ratio of C-reactive protein to prealbumin (C:P ratio).

Methods: A database of 89 patients with gastrointestinal fistulas (1994-2009) was created based on the records of our Nutrition Support Services Team. All patients had weekly blood work including C-reactive protein level, prealbumin level, and albumin level. Forty-three fistulas were managed without surgery for 6 weeks or more; of these, 29 closed.

Continue reading →

Calculation of essential metabolites in total parenteral nutrition (TPN): the basics

Posted on by
Reply

Madsen H, Frankel EH. The hitchhiker’s guide to parenteral nutrition management for adult patients. Practical Gastroenterology. 2006 Jul;30(7):46.

Summary: This was discussed as a possible question on boards. Below are three tables, taken directly from the article referenced.

p. 48
Continue reading →

Essential articles: Cardiothoracic/Cardiac

Posted on by
Reply

Emory users, open this instance of PubMed, then click the links below for full-text article access.

Khan JM, et al. Transcatheter Electrosurgery: JACC State-of-the-Art Review J Am Coll Cardiol. 2020 Mar 31;75(12):1455-1470. doi: 10.1016/j.jacc.2020.01.035. 

Editors. American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support J Heart Lung Transplant. 2020 Mar;39(3):187-219. doi: 10.1016/j.healun.2020.01.1329. 

Giustino G, et al. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial JACC Cardiovasc Interv. 2020 Feb 10;13(3):375-387. doi: 10.1016/j.jcin.2019.09.019. 

Holm NR, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised  non-inferiority NOBLE trial Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. 

Seese L, et al. The Impact of Major Postoperative Complications on Long-Term Survival After Cardiac Surgery Ann Thorac Surg. 2020 Jul;110(1):128-135. doi: 10.1016/j.athoracsur.2019.09.100. 

Continue reading →

Article of interest: Outcome of aggressive surveillance colonoscopy in ruptured abdominal aortic aneurysm.

Posted on by
Reply

Champagne BJ, et al. Outcome of aggressive surveillance colonoscopy in ruptured abdominal aortic aneurysm. J Vasc Surg. 2004 Apr;39(4):792-6.

Purpose: Emergent repair of ruptured abdominal aortic aneurysms (rAAAs) is associated with high perioperative morbidity and mortality. One of the significant complications of this surgery is bowel ischemia. Reports detail mortality as high as 80% when this condition is realized. The objective of this project was to determine both the incidence and the effect of mandatory postoperative colonoscopy on outcome of colon ischemia after rAAA.

Methods: From July 1995 to September 2002 all patients with an rAAA who underwent emergent aortic reconstruction were included in this review. All colonoscopies were performed within 48 hours, ischemia was graded consistently, and treatment was initiated per protocol based on grade of ischemia. Patients with grades I and II ischemia were followed up with medical management and repeat colonoscopy. All patients with grade III ischemia underwent bowel resection. Preoperative, intraoperative, and postoperative variables were collected to assess possible independent risk factors for and predictors of bowel ischemia.

Continue reading →

ASO Landmark Series

Posted on by
1
Emory users, open this instance of PubMed, then click the links below for full-text article access.

McMasters KM. Introducing: The Landmark Series. Ann Surg Oncol. 2020 Jan;27(1):1-2.

The Annals of Surgical Oncology, the journal of the Society of Surgical Oncology, has created The Landmark Article Series.

“The Landmark Series is designed to trace the origins of current multidisciplinary therapy for each type of solid tumor, and demonstrate the logical progression of clinical trials and other key evidence. It is meant to be an educational resource, for trainees and practicing cancer specialists alike, in the understanding of evidence-based cancer management. Practice-changing clinical trials and other key evidence that inform our current treatment guidelines will be summarized and reviewed. Expert authors will provide context and commentary to enhance the value to the reader.” (McMasters, p.1).

See the most current collection of articles sorted by disease site here. Emory users, use this link to access the full-text.

Beasley GM, et al. The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma. Ann Surg Oncol. 2020 Jan;27(1):35-42.

Egger ME, et al. The Sunbelt Melanoma Trial. Ann Surg Oncol. 2020 Jan;27(1):28-34.

Bello DM, Faries MB. The Landmark Series: MSLT-1, MSLT-2 and DeCOG
(Management of Lymph Nodes). Ann Surg Oncol. 2020 Jan;27(1):15-21.

Continue reading →